218 related articles for article (PubMed ID: 1279422)
1. Post-transfusion hepatitis C virus infection.
Kleinman S; Busch M; Holland P
N Engl J Med; 1992 Nov; 327(22):1601-2. PubMed ID: 1279422
[No Abstract] [Full Text] [Related]
2. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
Chung HT; Lee JS; Lok AS
Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
[TBL] [Abstract][Full Text] [Related]
3. The declining risk of post-transfusion hepatitis C virus infection.
Donahue JG; Muñoz A; Ness PM; Brown DE; Yawn DH; McAllister HA; Reitz BA; Nelson KE
N Engl J Med; 1992 Aug; 327(6):369-73. PubMed ID: 1320736
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients].
Sugg U
Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972
[No Abstract] [Full Text] [Related]
5. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
6. [Examination of a Berlin blood donation branch for antibodies to hepatitis C virus with the anti-HCV test and for circulating HCV-RNA using polymerase chain reaction].
Zimmermann R; König V; Bauditz J; Zeiler T; Zingsem J; Heuft HG; Hopf U; Huhn D; Eckstein R
Beitr Infusionsther; 1992; 30():38-41. PubMed ID: 1284740
[TBL] [Abstract][Full Text] [Related]
7. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to hepatitis B core antigen as a means of preventing post-transfusion hepatitis.
Takano S; Omata M; Ohto M; Nakamura K
Gastroenterol Jpn; 1993 May; 28 Suppl 5():84-7. PubMed ID: 7689514
[TBL] [Abstract][Full Text] [Related]
8. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
Janot C
Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
[No Abstract] [Full Text] [Related]
9. Hepatitis C virus seroprevalence in the developmentally disabled.
Levinson WM; Wormser GP; Forseter G; Calmann M; O'Brien TA
Arch Intern Med; 1992 Nov; 152(11):2309-11. PubMed ID: 1280075
[TBL] [Abstract][Full Text] [Related]
10. Non-B post-transfusion hepatitis with hepatitis B core antibodies in donor blood.
Katchaki JN; Siem TH; Brouwer R
N Engl J Med; 1982 Sep; 307(10):628-9. PubMed ID: 6810169
[No Abstract] [Full Text] [Related]
11. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
12. Non-B post-transfusion hepatitis associated with hepatitis B core antibodies in donor blood.
Vyas GN; Perkins HA
N Engl J Med; 1982 Mar; 306(12):749-50. PubMed ID: 6801510
[No Abstract] [Full Text] [Related]
13. [Prevention for hepatitis C virus transmission].
Sekiguchi S
Hokkaido Igaku Zasshi; 1993 Jul; 68(4):473-6. PubMed ID: 7687974
[No Abstract] [Full Text] [Related]
14. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis.
Kline WE
Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834
[No Abstract] [Full Text] [Related]
15. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Japanese Red Cross Non-A, Non-B Hepatitis Research Group.
Lancet; 1991 Oct; 338(8774):1040-1. PubMed ID: 1681356
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to hepatitis C virus infection after liver transplantation.
Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
[TBL] [Abstract][Full Text] [Related]
17. [Massive and multi-transfusions in polytraumatized patients: long-term serologic markers of hepatitis B, hepatitis C and AIDS].
Schneck HJ; Dobler G; Hundelshausen B; Nathrath M; Drescher M
Infusionstherapie; 1991 Oct; 18(5):248-55. PubMed ID: 1663086
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
Abb J
Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
[TBL] [Abstract][Full Text] [Related]
19. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
Takano S; Omata M; Ohto M; Satomura Y
Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Infusionsther Transfusionsmed; 1992 Jun; 19(3):157-9. PubMed ID: 1379861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]